PHARMACY

Lilly donates $4 million for tuberculosis drug discovery

BY Alaric DeArment

SEATTLE — Drug maker Eli Lilly is donating more than $4 million to the Infectious Disease Research Institute, the company said Thursday.

The company said the funding, which brings its total donations to IDRI to more than $20 million and its total funding for anti-tuberculosis efforts to more than $170 million, will support early-phase drug discovery efforts focused on identifying new drugs for tuberculosis, including strains of the virus that have grown resistant to multiple drugs. The Lilly TB Drug Discovery Initiative was started in 2007.

"While preventable and treatable, nearly 1.5 million people die from TB and [multidrug-resistant] TB every year," Lilly chairman, president and CEO John Lechleiter said. "Today’s TB drugs are decades old and must be taken for extended periods of time, which present challenges for patients and healthcare providers."


Interested in this topic? Sign up for our weekly Retail Health Provider e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

Former Mercer executive named president of CVS Caremark’s Accordant business

BY Antoinette Alexander

WOONSOCKET, R.I. — CVS Caremark has appointed Kevin Murphy president for Accordant Health Services, a CVS Caremark company that provides disease management and case management services for people with rare chronic conditions.

Murphy is in charge of integrating the company’s leading rare disease management programs with its specialty pharmacy programs and new focus on medical pharmacy management.

"Kevin Murphy’s in-depth experience in specialty pharmacy, knowledge of the industry and strong client management background make him uniquely qualified to lead the Accordant business," stated Troyen A. Brennan, EVP and chief medical officer of CVS Caremark.  "His expertise will enable us to further enhance our offerings focused on disease management for complex chronic diseases and identify innovative approaches to help these patients on their path to better health."

Murphy brings more than 20 years of experience in marketing, strategy and product development to CVS Caremark. He joined the company from Mercer, where he was a partner in the human resource consulting practice. Previously, Murphy led the market, strategy and development organization of Accredo, Medco’s specialty pharmacy division.  While at Medco, as well as in a previous position with Physicians Health Services, Murphy held various leadership roles in sales, marketing, and product development.


Interested in this topic? Sign up for our weekly Retail Health Provider e-newsletter.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

Walgreens retains network covering almost 3 million lives

BY Michael Johnsen

NEW YORK — EmblemHealth and Walgreens have reached an agreement that allows EmblemHealth and Connecticare members to continue to have access to the Walgreens pharmacy network in 2012, the companies announced Thursday.

EmblemHealth, through its companies Group Health Incorporated and HIP Health Plan of New York, provides healthcare coverage and administrative services to approximately 2.9 million people, the company said. 

"This agreement ensures that EmblemHealth and Connecticare members will have convenient and timely access to their medications near their homes or when they travel around the country, and is evidence of the commitment Walgreens has in working with health plans and other payers to continue serving our patients and customers," said Kermit Crawford, Walgreens president of pharmacy, health-and-wellness solutions and services.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES